Aktis Oncology, Inc. - Common Stock, $0.0001 par value per share (AKTSQ) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2017 to Q2 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
AKTSQ
Shares outstanding
53,311,882
Price per share
$0.01
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aktis Oncology, Inc. - Common Stock, $0.0001 par value per share (AKTSQ) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ELI LILLY & Co 12% $63,441 6,344,114 Eli Lilly and Company 12 Jan 2026

Institutional Holders of Aktis Oncology, Inc. - Common Stock, $0.0001 par value per share (AKTSQ) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q2 0 $0 -$186 $0.01 0
2025 Q1 28,756 $186 -$2,201 $0.01 2
2024 Q4 508,769 $2,571 -$1,764,188 $0.00 7
2024 Q3 21,078,132 $1,886,943 -$264,609 $0.09 73
2024 Q2 22,429,430 $2,953,111 -$6,546,259 $0.13 85
2024 Q1 40,683,545 $24,033,671 +$6,841,206 $0.59 113
2023 Q4 0 $0 -$94 $0.01 0
2023 Q3 32,788,797 $24,686,508 -$17,249,412 $0.75 112
2023 Q2 37,132,718 $118,051,302 +$4,164,963 $3.18 126
2023 Q1 35,760,337 $110,147,302 +$32,192,780 $3.08 132
2022 Q4 25,811,662 $72,787,349 -$3,171,704 $2.82 113
2022 Q3 27,665,826 $82,169,212 -$2,014,486 $2.97 111
2022 Q2 28,226,351 $104,434,931 -$2,452,198 $3.70 113
2022 Q1 28,788,537 $187,051,294 +$9,165,136 $6.50 121
2021 Q4 26,998,435 $178,487,761 +$4,040,397 $6.68 139
2021 Q3 26,211,824 $251,291,160 +$15,346,293 $9.70 135
2021 Q2 24,621,800 $262,606,325 +$18,453,955 $10.71 134
2021 Q1 22,634,198 $295,242,079 +$45,592,148 $13.34 141
2020 Q4 17,559,575 $214,749,243 +$34,777,648 $12.23 120
2020 Q3 13,269,342 $108,279,011 +$570,783 $8.16 101
2020 Q2 14,595,643 $120,976,455 +$6,276,362 $8.29 105
2020 Q1 14,535,046 $77,960,440 -$7,372,986 $5.37 91
2019 Q4 14,740,229 $117,926,072 +$41,797,915 $8.00 94
2019 Q3 9,554,148 $74,013,410 -$10,638,714 $7.75 81
2019 Q2 11,141,532 $71,300,191 +$28,371,347 $6.40 72
2019 Q1 6,627,120 $38,499,965 +$3,577,882 $5.81 60
2018 Q4 6,194,454 $30,782,708 +$11,757,445 $4.97 51
2018 Q3 3,358,200 $26,439,108 +$938,109 $7.87 38
2018 Q2 3,246,429 $23,591,651 +$962,516 $7.27 36
2018 Q1 3,171,331 $18,468,690 +$2,381,400 $5.83 40
2017 Q4 2,760,513 $17,208,534 +$2,648,570 $6.23 41
2017 Q3 2,096,887 $13,668,502 +$4,488,820 $6.52 31
2017 Q2 1,389,172 $12,132,953 +$3,180,324 $8.74 28
2017 Q1 742,987 $9,416,000 +$9,415,994 $12.84 13